Research in practice: Disturbance in intracellular nucleic acid metabolism promotes lupus erythematosus
- PMID: 33586881
- DOI: 10.1111/ddg.14357
Research in practice: Disturbance in intracellular nucleic acid metabolism promotes lupus erythematosus
Abstract
Lupus erythematosus (LE) is an autoimmune disease with a broad spectrum of cutaneous manifestations. It is characterized by a loss of tolerance to nuclear antigens, including endogenous nucleic acids, autoantibody formation and upregulation of the type I interferon pathway. This can be induced by an immune response to unrestricted extracellular self-antigens. In addition, the molecular characterization of rare monogenic subtypes of LE has revealed insights into the role of cell-intrinsic sensing of endogenous self-nucleic acids in inducing a type I interferon response. This pathway can also initiate and sustain LE. The enhanced understanding of innate and adaptive immune responses in LE is a prerequisite for the development of more targeted therapies.
© 2021 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.
References
Reference
-
- Liu Z, Davidson A. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med 2012; 18: 871-82.
-
- Hejazi EZ, Werth VP. Cutaneous lupus erythematosus: An update on pathogenesis, diagnosis and treatment. Am J Clin Dermatol 2016; 17: 135-46.
-
- Lintner KE, Wu YL, Yang Y et al. Early components of the complement classical activation pathway in human systemic autoimmune diseases. Front Immunol 2016; 7: 36.
-
- Yasutomo K, Horiuchi T, Kagami S et al. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 2001; 28: 313-4.
-
- Günther C. Nucleic Acid immunity in the pathogenesis of cutaneous lupus erythematosus. Front Immunol 2019; 10: 1636.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
